Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Research

Remote ischemic preconditioning preserves Connexin 43 phosphorylation in the rat heart in vivo

Authors: Timo Brandenburger, Ragnar Huhn, Andreas Galas, Benedikt H Pannen, Verena Keitel, Franziska Barthel, Inge Bauer, André Heinen

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

Background

Remote ischemic preconditioning (RIPC) protects the heart from ischemia and reperfusion (I/R) injury. The underlying molecular mechanisms are unclear. It has been demonstrated that Connexin 43 (Cx43) is critically involved in cardioprotective interventions including classical ischemic preconditioning. In the present study we investigated the influence of RIPC on the expression patterns of Cx43 after I/R in the rat heart in vivo.

Methods

Male Wistar rats were subjected to 35 min regional myocardial ischemia followed by 2 h reperfusion with or without 4 cycles of 5 minutes bilateral hind limb ischemia and reperfusion (RIPC), to RIPC without ischemia or underwent no intervention (Sham). Infarct size was measured by TTC staining. The myocardium was divided into area at risk (AAR) and area not at risk (non AAR). Expression of Cx43-mRNA and protein was analyzed by qPCR and Western Blot analysis, respectively. Localization of Cx43 was visualized by confocal immunofluorescence staining.

Results

RIPC reduced the infarct size (I/R: 73 ± 5% vs. RIPC I/R: 34 ± 14%, p < 0.05). Expression of Cx43 mRNA did not differ between groups. I/R caused a strong decrease of relative Cx43 protein expression in the AAR that was partly abolished by RIPC. Furthermore, RIPC decreased the level of ischemia-induced dephosphorylation of Cx43. Confocal immunofluorescence staining showed that I/R caused a loss of the Cx43 signal at the intercalated discs, while the Cx43 signal at the intercalated discs was partly sustained after RIPC.

Conclusion

Preservation of Cx43 protein expression and phosphorylation after RIPC might protect the rat heart in vivo.
Appendix
Available only for authorised users
Literature
1.
go back to reference Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P: Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993, 87: 893-899. 10.1161/01.CIR.87.3.893.CrossRefPubMed Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P: Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993, 87: 893-899. 10.1161/01.CIR.87.3.893.CrossRefPubMed
2.
go back to reference Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R: Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002, 106: 2881-2883. 10.1161/01.CIR.0000043806.51912.9B.CrossRefPubMed Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R: Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002, 106: 2881-2883. 10.1161/01.CIR.0000043806.51912.9B.CrossRefPubMed
3.
go back to reference Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010, 375: 727-734. 10.1016/S0140-6736(09)62001-8.CrossRefPubMed Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010, 375: 727-734. 10.1016/S0140-6736(09)62001-8.CrossRefPubMed
4.
go back to reference Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G: Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013, 382: 597-604. 10.1016/S0140-6736(13)61450-6.CrossRefPubMed Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G: Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet. 2013, 382: 597-604. 10.1016/S0140-6736(13)61450-6.CrossRefPubMed
5.
go back to reference Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, Konietzka I, Miro E, Totzeck A, Heusch G, Schulz R, Garcia-Dorado D: Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res. 2006, 99: 93-101. 10.1161/01.RES.0000230315.56904.de.CrossRefPubMed Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, Konietzka I, Miro E, Totzeck A, Heusch G, Schulz R, Garcia-Dorado D: Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res. 2006, 99: 93-101. 10.1161/01.RES.0000230315.56904.de.CrossRefPubMed
6.
go back to reference Davis LM, Kanter HL, Beyer EC, Saffitz JE: Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol. 1994, 24: 1124-1132. 10.1016/0735-1097(94)90879-6.CrossRefPubMed Davis LM, Kanter HL, Beyer EC, Saffitz JE: Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol. 1994, 24: 1124-1132. 10.1016/0735-1097(94)90879-6.CrossRefPubMed
7.
go back to reference Schulz R, Heusch G: Connexin 43 and ischemic preconditioning. Cardiovasc Res. 2004, 62: 335-344. 10.1016/j.cardiores.2003.12.017.CrossRefPubMed Schulz R, Heusch G: Connexin 43 and ischemic preconditioning. Cardiovasc Res. 2004, 62: 335-344. 10.1016/j.cardiores.2003.12.017.CrossRefPubMed
8.
go back to reference John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN: Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem. 1999, 274: 236-240. 10.1074/jbc.274.1.236.CrossRefPubMed John SA, Kondo R, Wang SY, Goldhaber JI, Weiss JN: Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem. 1999, 274: 236-240. 10.1074/jbc.274.1.236.CrossRefPubMed
9.
go back to reference Vetterlein F, Muhlfeld C, Cetegen C, Volkmann R, Schrader C, Hellige G: Redistribution of connexin43 in regional acute ischemic myocardium: influence of ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2006, 291: H813-H819. 10.1152/ajpheart.01177.2005.CrossRefPubMed Vetterlein F, Muhlfeld C, Cetegen C, Volkmann R, Schrader C, Hellige G: Redistribution of connexin43 in regional acute ischemic myocardium: influence of ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2006, 291: H813-H819. 10.1152/ajpheart.01177.2005.CrossRefPubMed
10.
go back to reference Tansey EE, Kwaku KF, Hammer PE, Cowan DB, Federman M, Levitsky S, McCully JD: Reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion. Ann Thorac Surg. 2006, 82: 1472-1479. 10.1016/j.athoracsur.2006.04.061.PubMedCentralCrossRefPubMed Tansey EE, Kwaku KF, Hammer PE, Cowan DB, Federman M, Levitsky S, McCully JD: Reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion. Ann Thorac Surg. 2006, 82: 1472-1479. 10.1016/j.athoracsur.2006.04.061.PubMedCentralCrossRefPubMed
11.
go back to reference Jain SK, Schuessler RB, Saffitz JE: Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res. 2003, 92: 1138-1144. 10.1161/01.RES.0000074883.66422.C5.CrossRefPubMed Jain SK, Schuessler RB, Saffitz JE: Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res. 2003, 92: 1138-1144. 10.1161/01.RES.0000074883.66422.C5.CrossRefPubMed
12.
go back to reference Schwanke U, Li X, Schulz R, Heusch G: No ischemic preconditioning in heterozygous connexin 43-deficient mice–a further in vivo study. Basic Res Cardiol. 2003, 98: 181-182.PubMed Schwanke U, Li X, Schulz R, Heusch G: No ischemic preconditioning in heterozygous connexin 43-deficient mice–a further in vivo study. Basic Res Cardiol. 2003, 98: 181-182.PubMed
13.
go back to reference Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G: No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol. 2002, 283: H1740-H1742.CrossRefPubMed Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G: No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol. 2002, 283: H1740-H1742.CrossRefPubMed
14.
go back to reference Heinen NM, Putz VE, Gorgens JI, Huhn R, Gruber Y, Barthuber C, Preckel B, Pannen BH, Bauer I: Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. Shock. 2011, 36: 45-53. 10.1097/SHK.0b013e31821d8e77.CrossRefPubMed Heinen NM, Putz VE, Gorgens JI, Huhn R, Gruber Y, Barthuber C, Preckel B, Pannen BH, Bauer I: Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic preconditioning. Shock. 2011, 36: 45-53. 10.1097/SHK.0b013e31821d8e77.CrossRefPubMed
15.
go back to reference Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC, Hollmann MW: Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2+) -sensitive potassium channel activation. Anesthesiology. 2008, 109: 830-836. 10.1097/ALN.0b013e3181895aa0.CrossRefPubMed Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC, Hollmann MW: Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2+) -sensitive potassium channel activation. Anesthesiology. 2008, 109: 830-836. 10.1097/ALN.0b013e3181895aa0.CrossRefPubMed
16.
17.
go back to reference Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30: e36-10.1093/nar/30.9.e36.PubMedCentralCrossRefPubMed Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30: e36-10.1093/nar/30.9.e36.PubMedCentralCrossRefPubMed
18.
19.
go back to reference Brandenburger T, Grievink H, Heinen N, Barthel F, Huhn R, Stachuletz F, Kohns M, Pannen B, Bauer I: Effects of remote ischemic preconditioning and myocardial ischemia on microRNA-1 expression in the rat heart in vivo.Shock 2014, [Epub ahead of print]., Brandenburger T, Grievink H, Heinen N, Barthel F, Huhn R, Stachuletz F, Kohns M, Pannen B, Bauer I: Effects of remote ischemic preconditioning and myocardial ischemia on microRNA-1 expression in the rat heart in vivo.Shock 2014, [Epub ahead of print].,
20.
go back to reference Hausenloy DJ, Yellon DM: Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008, 79: 377-386. 10.1093/cvr/cvn114.CrossRefPubMed Hausenloy DJ, Yellon DM: Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008, 79: 377-386. 10.1093/cvr/cvn114.CrossRefPubMed
21.
go back to reference Hausenloy DJ, Yellon DM: Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis. 2009, 204: 334-341. 10.1016/j.atherosclerosis.2008.10.029.CrossRefPubMed Hausenloy DJ, Yellon DM: Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis. 2009, 204: 334-341. 10.1016/j.atherosclerosis.2008.10.029.CrossRefPubMed
22.
go back to reference van Veen TA, van Rijen HV, Jongsma HJ: Physiology of cardiovascular gap junctions. Adv Cardiol. 2006, 42: 18-40. 10.1159/000092560.CrossRefPubMed van Veen TA, van Rijen HV, Jongsma HJ: Physiology of cardiovascular gap junctions. Adv Cardiol. 2006, 42: 18-40. 10.1159/000092560.CrossRefPubMed
23.
go back to reference Solan JL, Marquez-Rosado L, Sorgen PL, Thornton PJ, Gafken PR, Lampe PD: Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC. J Cell Biol. 2007, 179: 1301-1309. 10.1083/jcb.200707060.PubMedCentralCrossRefPubMed Solan JL, Marquez-Rosado L, Sorgen PL, Thornton PJ, Gafken PR, Lampe PD: Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC. J Cell Biol. 2007, 179: 1301-1309. 10.1083/jcb.200707060.PubMedCentralCrossRefPubMed
24.
go back to reference Jeyaraman MM, Srisakuldee W, Nickel BE, Kardami E: Connexin43 phosphorylation and cytoprotection in the heart. Biochim Biophys Acta. 1818, 2012: 2009-2013. Jeyaraman MM, Srisakuldee W, Nickel BE, Kardami E: Connexin43 phosphorylation and cytoprotection in the heart. Biochim Biophys Acta. 1818, 2012: 2009-2013.
25.
go back to reference Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kleber AG, Schuessler RB, Saffitz JE: Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res. 2000, 87: 656-662. 10.1161/01.RES.87.8.656.CrossRefPubMed Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kleber AG, Schuessler RB, Saffitz JE: Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res. 2000, 87: 656-662. 10.1161/01.RES.87.8.656.CrossRefPubMed
26.
go back to reference Huang XD, Sandusky GE, Zipes DP: Heterogeneous loss of connexin43 protein in ischemic dog hearts. J Cardiovasc Electrophysiol. 1999, 10: 79-91. 10.1111/j.1540-8167.1999.tb00645.x.CrossRefPubMed Huang XD, Sandusky GE, Zipes DP: Heterogeneous loss of connexin43 protein in ischemic dog hearts. J Cardiovasc Electrophysiol. 1999, 10: 79-91. 10.1111/j.1540-8167.1999.tb00645.x.CrossRefPubMed
27.
go back to reference Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G: Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. Faseb J. 2003, 17: 1355-1357.PubMed Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G: Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. Faseb J. 2003, 17: 1355-1357.PubMed
28.
go back to reference Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, Barrabes JA, Soler-Soler J: Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation. 1997, 96: 3579-3586. 10.1161/01.CIR.96.10.3579.CrossRefPubMed Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, Barrabes JA, Soler-Soler J: Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation. 1997, 96: 3579-3586. 10.1161/01.CIR.96.10.3579.CrossRefPubMed
29.
go back to reference Azzam EI, de Toledo SM, Little JB: Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A. 2001, 98: 473-478.PubMedCentralPubMed Azzam EI, de Toledo SM, Little JB: Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A. 2001, 98: 473-478.PubMedCentralPubMed
30.
go back to reference Zeevi-Levin N, Barac YD, Reisner Y, Reiter I, Yaniv G, Meiry G, Abassi Z, Kostin S, Schaper J, Rosen MR, Resnick N, Binah O: Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res. 2005, 66: 64-73. 10.1016/j.cardiores.2005.01.014.CrossRefPubMed Zeevi-Levin N, Barac YD, Reisner Y, Reiter I, Yaniv G, Meiry G, Abassi Z, Kostin S, Schaper J, Rosen MR, Resnick N, Binah O: Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res. 2005, 66: 64-73. 10.1016/j.cardiores.2005.01.014.CrossRefPubMed
31.
go back to reference Sanchez JA, Rodriguez-Sinovas A, Barba I, Miro-Casas E, Fernandez-Sanz C, Ruiz-Meana M, Alburquerque-Bejar JJ, Garcia-Dorado D: Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection. Basic Res Cardiol. 2013, 108: 351-10.1007/s00395-013-0351-3.CrossRefPubMed Sanchez JA, Rodriguez-Sinovas A, Barba I, Miro-Casas E, Fernandez-Sanz C, Ruiz-Meana M, Alburquerque-Bejar JJ, Garcia-Dorado D: Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection. Basic Res Cardiol. 2013, 108: 351-10.1007/s00395-013-0351-3.CrossRefPubMed
32.
go back to reference Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I, Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, Heusch G, Schulz R: Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 2005, 67: 234-244. 10.1016/j.cardiores.2005.04.014.CrossRefPubMed Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I, Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, Heusch G, Schulz R: Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 2005, 67: 234-244. 10.1016/j.cardiores.2005.04.014.CrossRefPubMed
33.
go back to reference Ruiz-Meana M, Nunez E, Miro-Casas E, Martinez-Acedo P, Barba I, Rodriguez-Sinovas A, Inserte J, Fernandez-Sanz C, Hernando V, Vazquez J, Garcia-Dorado D: Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. J Mol Cell Cardiol. 2014, 68: 79-88. 10.1016/j.yjmcc.2014.01.001.CrossRefPubMed Ruiz-Meana M, Nunez E, Miro-Casas E, Martinez-Acedo P, Barba I, Rodriguez-Sinovas A, Inserte J, Fernandez-Sanz C, Hernando V, Vazquez J, Garcia-Dorado D: Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. J Mol Cell Cardiol. 2014, 68: 79-88. 10.1016/j.yjmcc.2014.01.001.CrossRefPubMed
Metadata
Title
Remote ischemic preconditioning preserves Connexin 43 phosphorylation in the rat heart in vivo
Authors
Timo Brandenburger
Ragnar Huhn
Andreas Galas
Benedikt H Pannen
Verena Keitel
Franziska Barthel
Inge Bauer
André Heinen
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-014-0228-8

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.